Human medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Prostatic Neoplasms, Date of authorisation: 29/09/2023, Status: Authorised

Human medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Prostatic Neoplasms, Date of authorisation: 29/09/2023, Status: Authorised

Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Constipation, Date of authorisation: 18/02/2019, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Rizmoic, naldemedine, Constipation, Date of authorisation: 18/02/2019, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Epilepsy, Date of authorisation: 29/08/2008, Revision: 46, Status: Authorised

Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Epilepsy, Date of authorisation: 29/08/2008, Revision: 46, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.